SLI
1.989,50
PKT
-2,84
PKT
-0,14
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
25.10.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
25.10.18 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
25.10.18 | ams-OSRAM buy | Deutsche Bank AG | |
25.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
25.10.18 | Novartis Hold | HSBC | |
25.10.18 | ams-OSRAM Neutral | Credit Suisse Group | |
24.10.18 | Swiss Re Outperform | Credit Suisse Group | |
24.10.18 | Givaudan overweight | JP Morgan Chase & Co. | |
24.10.18 | Holcim Neutral | JP Morgan Chase & Co. | |
24.10.18 | ams-OSRAM buy | Hauck & Aufhäuser Privatbankiers KGaA | |
24.10.18 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
23.10.18 | ams-OSRAM Neutral | UBS AG | |
23.10.18 | ams-OSRAM Outperform | Credit Suisse Group | |
23.10.18 | ams-OSRAM overweight | Barclays Capital | |
23.10.18 | UBS buy | Goldman Sachs Group Inc. | |
23.10.18 | UBS Neutral | Goldman Sachs Group Inc. | |
23.10.18 | Givaudan Sell | Goldman Sachs Group Inc. | |
23.10.18 | Roche Neutral | UBS AG | |
23.10.18 | Nestlé buy | Jefferies & Company Inc. | |
22.10.18 | ams-OSRAM overweight | JP Morgan Chase & Co. | |
22.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
22.10.18 | Roche overweight | JP Morgan Chase & Co. | |
22.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
22.10.18 | Swiss Re Hold | Deutsche Bank AG | |
22.10.18 | Roche Hold | Deutsche Bank AG | |
22.10.18 | Novartis Hold | Deutsche Bank AG | |
19.10.18 | Novartis Hold | Baader Bank | |
19.10.18 | Nestlé buy | CFRA | |
19.10.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
19.10.18 | Swiss Re Sell | UBS AG | |
19.10.18 | Nestlé Hold | Société Générale Group S.A. (SG) | |
19.10.18 | Zurich Insurance Equal weight | Barclays Capital | |
19.10.18 | Novartis Neutral | Credit Suisse Group | |
19.10.18 | Nestlé overweight | JP Morgan Chase & Co. | |
19.10.18 | Nestlé buy | Goldman Sachs Group Inc. | |
18.10.18 | Nestlé overweight | JP Morgan Chase & Co. | |
18.10.18 | Novartis buy | CFRA | |
18.10.18 | Holcim overweight | Morgan Stanley | |
18.10.18 | Roche overweight | JP Morgan Chase & Co. | |
18.10.18 | Holcim Neutral | JP Morgan Chase & Co. |